92S-19117-00151
4 vaccinations
10 coded responses
48 check-ins
10 free-text entries
3 call cases
- Sex
- Male
- Age at first dose
- 41-45
- ZIP prefix
- 606 / IL
- Registered
- 2021-03-28
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-25
Dose 1 — Pfizer-BioNTech
-
2021-03-28
Registered in v-safe
- 2021-03-28
-
2021-03-29
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Headache, Fatigue or tirednessAdult check-in
- 2021-03-30
- 2021-03-31
-
2021-04-01
Survey response — day 7, dose 1MedDRA: Lymph node pain — Feeling: Fair · Headache, Fatigue or tiredness, Abdominal painFree text: lymph node soreness in neck, primarily on shot sideMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-08
Survey response — day 14, dose 1MedDRA: Arthralgia, Myalgia, Paraesthesia — Feeling: FairFree text: I went through a few days of sore muscles and joints, as well as mild tingling in my feet, similar to standing all day.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-15
Dose 2 — Pfizer-BioNTech
- 2021-04-15
-
2021-04-16
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Headache, Joint pains, Muscle or body aches · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-04-17
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Fatigue or tiredness, Abdominal painAdult check-in
-
2021-04-18
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Fatigue or tiredness, Abdominal painAdult check-in
- 2021-04-19
- 2021-04-20
- 2021-04-21
- 2021-04-22
- 2021-04-29
- 2021-05-06
- 2021-05-13
- 2021-05-20
- 2021-05-27
-
2021-07-15
Survey response — 3 months, dose 2MedDRA: Constipation, Unevaluable event — Feeling: FairFree text: Constipation and reflux issuesMedDRA releases: 2021-09,2024-11 · check-in free text available
- 2021-10-14
-
2021-12-16
Dose 3 — Moderna
-
2021-12-18
Survey response — days 1–6 daily, dose 3MedDRA: Dyspnoea, Heart rate increased — Feeling: Poor · Site: Pain, Redness · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Diarrhea · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: shortness of breath, elevated heart rateMedDRA releases: 2024-11 · check-in free text available
-
2021-12-18
Report sent to call center — days 1–6 daily, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2021-12-19
Survey response — days 1–6 daily, dose 3MedDRA: Dyspnoea, Heart rate increased — Feeling: Fair · Site: Pain · Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: mild shortness of breath; above normal heart rate.MedDRA releases: 2024-11 · check-in free text available
-
2021-12-20
Survey response — days 1–6 daily, dose 3MedDRA: Heart rate increased — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: slightly elevated heartrateMedDRA releases: 2024-11 · check-in free text available
-
2021-12-20
Report sent to call center — days 1–6 daily, dose 3Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2021-12-21
Survey response — days 1–6 daily, dose 3MedDRA: Gastrooesophageal reflux disease, Heart rate increased, Vertigo — Feeling: Fair · Chills, Abdominal pain · Be unable to do your normal daily activitiesFree text: elevated heart rate, reflux, minor vertigoMedDRA releases: 2024-11 · check-in free text available
-
2021-12-22
Survey response — days 1–6 daily, dose 3MedDRA: Heart rate increased — Feeling: Fair · Muscle or body aches · Be unable to do your normal daily activitiesFree text: mild elevated heart rate.MedDRA releases: 2024-11 · check-in free text available
-
2021-12-22
Call successfulParticipant prefers to complete VAERS report online
- 2021-12-23
- 2021-12-30
- 2022-01-06
-
2022-01-13
Survey response — day 28, dose 3MedDRA: Back pain, Chest discomfort, Unevaluable event — Feeling: Fair · Get care from a doctor or other healthcare professionalFree text: Symptoms: Lungs feeling a bit of pressure, though no difficulty breathing. Occasional upper back surface pain, almost like icy-hot was applied. · Healthcare visit (other): awaiting recommendation for clinic visit or virtual from PCD, ongoingMedDRA releases: 2024-11 · check-in free text available
-
2022-01-13
Report sent to call center — day 28, dose 3Get care from a doctor or other healthcare professional1 call case(s)
- 2022-01-14
- 2022-01-19
- 2022-01-20
- 2022-01-27
- 2022-03-17
- 2022-06-16
-
2022-09-20
Dose 4 — Pfizer-BioNTech
-
2022-09-21
Health check-in — days 1–6 daily, dose 4Feeling: Poor · Site: Pain · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
- 2022-09-22
- 2022-09-23
- 2022-09-24
- 2022-09-25
- 2022-09-26
- 2022-09-27
-
2022-10-04
Survey response — day 14, dose 4MedDRA: Condition aggravated, Pre-existing disease — Feeling: FairFree text: A resurgence in acid reflux and related issuesMedDRA releases: 2024-11 · check-in free text available
- 2022-10-11
- 2022-10-18
- 2022-10-25
- 2022-11-01
- 2022-12-20
- 2023-03-21
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-25 | Pfizer-BioNTech | |
| 2 | 2021-04-15 | Pfizer-BioNTech | |
| 3 | 2021-12-16 | Moderna | No |
| 4 | 2022-09-20 | Pfizer-BioNTech | No |
Call center
3 call center cases
2 successful · 1 unsuccessful
Free text
Release 6 — day 7, dose 1
Systemic reaction (other): lymph node soreness in neck, primarily on shot side
Release 7 — day 14, dose 1
Symptoms: I went through a few days of sore muscles and joints, as well as mild tingling in my feet, similar to standing all day.
Release 9 — 3 months, dose 2
Symptoms: Constipation and reflux issues
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): shortness of breath, elevated heart rate
Systemic reaction (other): mild shortness of breath; above normal heart rate.
Systemic reaction (other): slightly elevated heartrate
Systemic reaction (other): elevated heart rate, reflux, minor vertigo
Systemic reaction (other): mild elevated heart rate.
Release 10 — day 28, dose 3
Symptoms: Lungs feeling a bit of pressure, though no difficulty breathing. Occasional upper back surface pain, almost like icy-hot was applied.
Healthcare visit (other): awaiting recommendation for clinic visit or virtual from PCD, ongoing
Release 12 — day 14, dose 4
Symptoms: A resurgence in acid reflux and related issues
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Unevaluable event | · | · | ✓ |
| SD | Arthralgia | ✓ | ✓ | ✓ |
| SD | Back pain | · | · | ✓ |
| SD | Chest discomfort | · | · | ✓ |
| SD | Condition aggravated | · | · | ✓ |
| SD | Constipation | ✓ | · | ✓ |
| SD | Myalgia | ✓ | ✓ | ✓ |
| SD | Paraesthesia | ✓ | ✓ | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Unevaluable event | ✓ | · | ✓ |
| SRO | Dyspnoea | · | · | ✓ |
| SRO | Gastrooesophageal reflux disease | · | · | ✓ |
| SRO | Heart rate increased | · | · | ✓ |
| SRO | Lymph node pain | ✓ | ✓ | ✓ |
| SRO | Vertigo | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release